Clinical Laboratory in Minnesota

Premier Biotech is a drug testing and diagnostics company offering integrated rapid and laboratory-based testing solutions. The company manufactures and operates OralTox®, a rapid oral fluid drug test recognized as the #1 brand in rapid oral fluid testing, paired with OT-Scan®, a digital results interpretation and reporting application for point-of-collection testing. Premier Biotech operates two CAP-accredited forensic laboratories (Minneapolis and Scottsdale) and SAMHSA-certified facilities supporting confirmatory testing and regulated drug testing programs. The company serves employers, healthcare providers, government agencies, background screening partners, and public-sector organizations across workplace testing, clinical testing, and government/criminal justice applications. Product lines include rapid oral fluid tests, lab-based oral fluid collection (Intercept i2he®), rapid urine screening, SAFE harm reduction test strips (detecting fentanyl, xylazine, nitazenes, benzodiazepines), and Premier Biotech Services (PBS), a full-service program administration offering including drug testing, background screening, reporting, and program management. The company emphasizes observed collection workflows, chain-of-custody procedures, customizable drug panels, and integrated end-to-end testing ecosystems. With nearly 20 years of experience in rapid diagnostics development, Premier Biotech positions itself as a stable, regulated partner with structured onboarding, training, and customer success support for compliance-driven and safety-sensitive environments. 510(k)-cleared devices are available with up to 8 drug panels.

Radiation Products Design, Inc. (RPD) is a specialized manufacturer and supplier of radiation therapy, diagnostic imaging, and nuclear medicine accessories and equipment. Based in Albertville, Minnesota, RPD serves medical physics, radiation oncology, and nuclear medicine departments across the United States. The company's product portfolio spans multiple therapeutic and diagnostic domains: radiation therapy positioning and immobilization systems (thermoplastic masks, vacuum cushions, head supports, breast positioning devices); brachytherapy applicators and accessories for both low-dose rate (LDR) and high-dose rate (HDR) gynecological applications; dosimetry and quality assurance equipment including build-up caps for ion chambers (Farmer, Exradin, PTW, Scanditronix/Wellhofer models), MOSFET and diode systems, electrometers, and radiation area monitors; CT simulator and imaging accessories such as CT chambers, phantoms, marking systems, and alignment lasers; shielding products including lead blocks, eye shields, tungsten shields, and mobile radiation barriers; calibration phantoms and water phantom systems; PET/nuclear medicine workstations, storage containers, and shipping systems; and sterilization/disinfection equipment and trays. RPD manufactures custom block room products (alloy dispensers, styrofoam blocks, cooling plates), bolus materials (Aquaplast, SuperFlab, moldable options), and precision beam modification tools. The company also supplies marking and positioning consumables, measuring instruments, lead-lined containers, and quality control devices (ISIS QA phantoms, beam analyzers). Products are compatible with major linear accelerator and imaging equipment manufacturers including Varian, Siemens, and Elekta. The company maintains a comprehensive PDF catalog and offers custom manufacturing for specialized applications. RPD serves hospital radiation oncology departments, medical physics groups, nuclear medicine facilities, and diagnostic imaging centers, providing both stock products and made-to-order solutions for radiation protection, dose verification, and treatment planning.

Viralab Inc. is the exclusive U.S. distributor for Viramed Biotech AG (Munich, Germany), a leading manufacturer of immunoblot reagents and diagnostic products for clinical and research laboratories. Founded in 2003, Viralab specializes in high-quality laboratory reagents for infectious disease serology testing, with particular expertise in Lyme disease (Borrelia burgdorferi) confirmation and screening. Product portfolio includes ViraChip and ViraStripe immunoblot systems for Borrelia (Lyme), SARS-CoV-2, Bordetella pertussis, and Helicobacter pylori detection across multiple antibody classes (IgG, IgM, IgA). The Borrelia All-In-One ViraChip was FDA-cleared in August 2022, providing both screening and confirmation in a single 2.5-hour assay. Viralab operates a 24-hour ordering system with next-day delivery capability and telephone support Monday–Friday 8 a.m.–5 p.m. Central Time. The company maintains strong relationships with major clinical laboratory associations including AACC and AMLI, and regularly exhibits at Clinical Virology Symposium and related professional conferences.

Surmodics, Inc. is a specialized medical device company focused on three core business segments: interventional endovascular products, performance coatings for intravascular medical devices, and in vitro diagnostic (IVD) chemical components. The company is a global leader in customized hydrophilic, hemocompatible, and drug-delivery surface coatings applied to complex intravascular devices for interventional cardiology, neurovascular, and peripheral vascular procedures. Surmodics manufactures and markets breakthrough endovascular thrombectomy and vascular access platforms, including the Pounce™ Thrombectomy Platform (for arterial and venous thrombi in vessels 2–16mm diameter range), Pounce™ Venous Thrombectomy System, and Sublime™ Radial Access Platform for radial-to-peripheral interventions. The company also provides Preside™ Hydrophilic Coatings for neuro, coronary, and peripheral device applications. As a Contract Development and Manufacturing Organization (CDMO), Surmodics offers end-to-end development and scalable manufacturing services for complex medical devices. In the IVD space, Surmodics supplies high-performance chemical components for immunoassay tests and microarray diagnostics, enabling signal amplification and noise reduction in diagnostic platforms. The company operates under FDA regulation, with products restricted to physician sale and use. Surmodics serves interventional radiologists, cardiologists, vascular surgeons, and diagnostic test manufacturers globally.